A. Mohamed Sikkander, C. Hazarathaiah Yadav and Narendra Revanuri (trans.) (2025) “A 2025 meta-analysis in non–small-cell lung cancer (NSCLC) indicates glucocorticoid administration is significantly associated with worse progression-free survival (PFS) and overall survival (OS) for patients on ICIs”, World Journal of Applied Medical Sciences, 2(11), pp. 1–3. doi:10.65336/WJAMS.2025.21101.